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Summary
Onchocerciasis (river blindness) isa majorblindingdisease in Africa, Central America, andSouth
America. Loss ofvision can be due to corneal change, optic atrophy, or chorioretinal disease.
It has been suggested that autoimmunological reactions resulting from crossreactivity between
parasite antigens and components ofeye tissues contribute to development ofocular pathology.
Using sera collected from onchocerciasis patients as a screening reagent, a cDNA clone (Ov39)
has been isolated from a Xgt11 expression library of Onchocerca volvulus. This antigen exhibits
immunological crossreactivity with a component of retinal pigment epithelium cells (RPE).
Antiserum raised against this recombinant peptide immunoprecipitates a 22,000 M, antigen of
adult O volvulus and recognizes a 44,000 M component of bovine RPE by Western blotting.
A 44,000 Mr antigen of cultured human RPE metabolically labeled with 35S-methionine can
be immunoprecipitated with the same antiserum. An antigen of the same size is recognized by
a rabbit antiserum raised against whole Q volvulus extract. Immunocytochemical studies on cryostat
sections of the bovine eye using the antirecombinant sera localizes this antigen to the RPE.
0
nchocercavolvulus is a filarial nematode and the causative
agent of onchocerciasis (river blindness) . The clinical
manifestations ofeye disease in onchocerciasis have been well
described (1-4) and include punctate keratitis, sclerosing ker-
atitis, iridocyclitis, optic neuritis, optic nerve atrophy, and
chorioretinitis. Inflammatory responses directed against dead
microfilariae may explain development ofpathological changes
in the anterior segment (5, 6), however, the aetiology of le-
sions in the posterior segment is unclear. In the'case of de-
generative chorioretinitis, migrating microfilariae (7, 8) and
direct interaction ofcellsof the immune system with micro-
filariae, accompanied by infiltrate oflymphocytes and plasma
cells, have been implicated in pathogenesis (discussed by Don-
nelly et al. [9]). In addition, lymphocyte-derived chemotactic
factors and direct chemotactic effects of microfilarial excre-
tions/secretions may also have a role in pathogenesis (10).
More recently, Vingtain et al. (11) have provided evidence
to support the idea that autoantibodies may play a significant
role in retinal damage. These investigators demonstrated the
presence of antibodies with specificity for bovine retinal S
antigen and human retinal extract in onchocerciasis patients
presenting with chorioretinitis. Van der Lelij et al. (12) ex-
tended these observations through experiments using purified
human S antigen and interphotoreceptor retinoid binding pro-
tein (IRBP) .t High levels of specific antibody were found in
onchocerciasis patients, but these studies failed to reveal an
association with chorioretinitis. In addition, Chan et al. (13)
demonstrated the presence of autoantibodies in infection sera
that could not be absorbed with either S antigen or IRBP;
rather, these antibodies were directed against the inner retina,
including the nerve fiber layer, ganglion cells, and Milller cells.
It is not clear, however, whether the occurrence of autoan-
tibodies in onchocerciasis patients is a secondary autoimmu-
nization to antigens released from damaged tissue due to an
underlying disease process, or whether it might be a primary
event that may be explained by crossreactivity between para-
site antigens and the retina. To help distinguish between these
alternatives, it will be necessary to identify and characterize
the crossreacting antigens. In this report, we described the
identification of a recombinant antigen of Q volvulus that
shares immunological crossreactivity with a component of
retinal pigment epithelium cells (RPE). The availability of
this recombinant antigen and the identification of the cross-
1 Abbreviations used in thispaper . iRBP,interphotoreceptor retinoid binding
protein; RPE, retinal pigment epithelium.
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pathogenesis ofthe chorioretinopathy seen in onchocerciasis.
Materials and Methods
Parasites andEye Tissue Material.
￿
Adult female andmale Q vol-
vulus wormswere isolated from excisednodulesbycollagenase diges-
tion of the encapsulating host tissue (14) and stored in liquid
nitrogen.
An aqueous antigen extract was prepared by homogenization
of parasites in PBScontaining 1 mM PMSF and 1 mM N-tosyl-L-
phenylalanine chloromethyl ketone (TPCK). Thehomogenate was
centrifuged at 10,000 g and the supernatant fluid collected. The
insoluble pellet was also recovered and solubilized in 1% SDS.
For SDS/PAGE, thesefractions, or whole worm extracts, were
resuspended in SDS samplebuffer (15) andgelloadings determined
empirically.
Bovine eyes were obtained from alocalabattoire and transported
to the laboratory on ice for immediate processing.
To prepare extracts for PAGE/Western blot experiments, bo-
vine eyes were bisected in the equatorial plane, the vitreous and
neuroretina removed, and the eye cup filled with calcium and
magnesium-free PBS, pH 7.4,containing 20 mM EDTA (tetra so-
dium salt) . After 1 h at room temperature, cells of theretinal pig-
ment epithelium couldbe removedfrom Bruch's membrane by gentle
pipetting. Detached cells were washed twice in PBS. Soluble and
cytoskeletal fractions were produced by dissolving the cellsin PBS
containing 1% Triton X-100and 1 mM PMSF. Theresulting frac-
tions were then mixed with SDS sample buffer (15) and boiled for
5 min. Appropriate gelloadings forWesternblotswere determined
empirically.
Cultured human RPE were obtained from the Department of
Pathology, Instituteof Ophthalmology (London), and maintained
and harvested, as described by Boulton et al. (16). Components
of RPE cells were sequentially extracted in: (a) an aqueous solu-
tion of PBS; (b) in PBS, 1% Triton X-100; and (c) in PBS, 0.1%
SDS, for subsequent use in immunoprecipitation experiments.
Source ofAntisera.
￿
Antisera used in immunological assays came
from two sources. First, human onchocerciasis infection sera col-
lected from patients participating in clinical and epidemiological
surveys carried out in Sierra Leoneby McMahon (17) and Whit-
worth (18). Second, antisera raised in rabbits after immunization
with purified or semi-purifiedproteins, includingrecombinant an-
tigens, in the presence of CFA.
Humaninfection sera were extensively preabsorbed against whole
bacterial extracts ofEscherichia coli andpure ,(3-galactosidase before
their subsequent use in immunological screening methods and
Western blot technique. The extract was prepared from overnight
cultures ofE. coli PM1090, 50 timesconcentrated in 10 mM Tris,
pH 7.5, saline solution with 1 mM PMSF. Theconcentrated cells
were sonicated and incubated at 37°C for 12 h with 1 mg/ml
DNAse. (3-galactosidase wasaddedat aconcentration of0.2 mg/ml,
and theextractwas stored frozen. 200pl ofhumaninfection serum
was absorbed against 3 x 1 ml of this extract and subsequently
against a 63-cm' nitrocellulose filter coated with 1 mg 0-galac-
tosidase.
Labeling Procedures andImmunoprecipitations ofAntigens.
￿
Native
antigens were labeled with 35S using 35S labeling reagent (Amer-
sham, Buckinghamshire, UK), according to themanufacturer's in-
structions.
The mRNA directed in vitro translation products were radiola-
beled with "S-methionine using the rabbit reticulocyte lysate
system (19) following the method described by Taylor et al. (20).
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Cultured humanretinalpigmentepithelial cellswere maintained
in one 75-cm' tissue culture flask as describedelsewhere (16). For
metabolic labeling, the culture medium was supplemented with
500,uCi (1,000 Ci/mmol) 31S-methionine. After several washes in
PBS, the cells were harvested and sonicated before extraction as
described above.
Immunoprecipitation of radiolabeled antigens was carried out
as previously described (20) using 600,000 dpm per immunopre-
cipitation reaction. NP-40 was added to samples containing SDS
in a ratio of 2.5:1 (wt/wt) before addition of the antiserum.
SDS/PAGE and Western BlotAnalysis.
￿
SDS/PAGE (concentra-
tions of the slab gels are indicated in the figure legends) was
performed as describedby Laemmli (15). Electrophoretically sepa-
ratedpolypeptides were transferred to nitrocellulose paper (BA85;
Schleicher & Schull GmbH, Dassel, FRG) by overnight blotting
at 100mA (bovine retinalantigens) or 400mA for 2h(Q volvulus
recombinant antigens)followingthemethod ofTowbin et al. (21).
Immunostaining ofbovine retinalextractwascarried outaccording
to themethod describedby Campbell (22). Theprimary antibody
was used at a dilution of 1:300. Goat anti-rabbit peroxidase con-
jugate (used at 1:50 dilution) was obtained from SigmaChemical
Co. (Poole, Dorset, UK).
Aftertransfer of Q volvulus recombinant antigens, thenitrocel-
lulose filter was "blocked"by incubation with PBScontaining 1%
BSA for 15 min and subsequently incubated with the first anti-
body (1:400 diluted in washingbuffer: PBScontaining 0.3% Tween
20) overnight at 4°C. Afterfive washes in washingbuffer, theblot
was incubated for 1 h at room temperature with an appropriate
biotinylated second antibody and again washed with five changes
of washing buffer (1 h). The blot was then incubatedwith strep-
tavidin-horseradish peroxidase. The second antibody and peroxi-
dase complexwere purchasedfrom Amersham, and used at adilu-
tion of 1:400in washingbuffer. Afterfive furtherwashes inwashing
buffer, theblot was developedin Incubation Solution, which was
made up fresh mixing 0.6 mg/ml 4-chloro-l-naphthol in meth-
anol with PBS in a ratio of 1:5. 0.06% Hydrogen peroxide was
added to the incubation solution shortly before use.
Indirect Immunofuorescence Studies.
￿
Cryostat sections ofbovine
neuroretina and RPE were prepared from fresh bovine eyes. The
sections were air dried only and notchemically fixed. Nonspecific
binding of Igs was blocked by a 20-min incubation in PBS con-
taining 5% normal goat serum. Allantibody dilutions were made
up in 1% normal goat serum. Primary antibodies were used at a
rangeofconcentrations between 1:50 and 1:200. Sections were in-
cubated with the primary antibody for 2 h. After several washes
in PBS, bindingof Igswas detected by a 1-h incubation with goat
anti-rabbit FITC conjugate (Sigma Chemical Co.), diluted 1:40.
After further washes in PBS, sections were mounted on Flurostab
(Bio-nuclear Services Ltd., Reading, UK) andexamined, andpho-
tographed, using a Dialux microscope (Leitz, Wetzlar, FRG)
equipped with filters for epi-fluorescent microscopy. All photo-
graphic exposures were of the same duration to facilitate compar-
ison. Controls for immunocytochemical specificity were: (a)omis-
sion of the primary antibody; (b) the use of sera obtained from
the rabbit before immunization at the same dilution as the test
sera; (c) the use of sera directed against the carrier peptide of the
fusion protein.
Bacterial Strains and Growth Conditions.
￿
The phage Agt11 was
grown in bacterial strains using standard methods (23). For the
production of the Ov39 fusion protein with the /3-galactosidase,
the temperature-sensitive lysogen of Xgt11 recombinant phage in
E.coliY1089wasshiftedfrom 30°Cto 42°C, inducedwith isopropyl
thio-o-D-galactopyranoside (IPTG) during theexponential growth
Crossreactivity of Onchocerca volvulus with Retinal Pigment Epitheliumphase, and harvested before lysis occurred. The expression vectors
pEX34b (23),pGEXI (24), and theirderivatives were transformed
into E. coli 537 and E. coli TG2, respectively. For the production
andpurification offusion protein in the respective bacterial strains,
expression was induced following procedures described by Klinkert
et al. (24) and Smith et al. (25).
For the isolation ofphageDNA, Xgt11 recombinant phage was
prepared from a 100-ml culture (luria broth, 50 mg/ml ampicillin,
0.1% glucose, 2 MM MgS04). E. coli Y1088 cells were grown
overnight in 3 ml of luria broth, 50 mg/ml ampicillin, 0.2% mal-
tose. The cells were centrifuged, resuspended in 3 ml 10 mM
MgS04, and used for the inoculation of the 100-ml culture. To
propagate the phage, this culture was immediately infected with
3 x 106 plaque-forming units and grown overnight at 37°C.
After pelleting the remaining bacteria, the supernatant was retained
for the recovery of the phage.
Preparation ofDNA and RNA.
￿
Genomic DNA from Q vol-
vulus, Brugia malayi, Acanthocheilonerna vitae, Loa loa, and human
DNA from a hybrid cell line ESH98 (26), was isolated from
homogenized material treated with proteinaseK in sarcosyl/EDTA,
as described in Maniatis et al. (27). Genomic DNA of Q gibsoni,
Q gutturosa, Q armifata, andR pahangi, and cow DNA, was kindly
provided by R. Post (University of Salford).
For the preparation of phage DNA, culture supernatant con-
taining Xgt11 phage particles was incubated at 37°C for 1 h with
40 ug/ml RNase and 20 i4g/ml DNase. The phage was precipi-
tated with 20 ml of 20% polyethylene glycol 8000, 2.5 M NaCl
during an incubation period of 2 h on ice, and pelleted at 18,000
rpm (GSA Sorvall rotor; DuPont Co., Wilmington, DE) for 45
min. The phage pellet was carefully resuspended in 2 ml 10 mM
Tris, pH 7.5, 1 mM EDTA (TE), and treated for 10 min with 20
mM EDTA. DNA was extracted with 1 ml ofphenol. Three fur-
ther extractions of the aqueous phase with phenol/CHCb (27) fol-
lowed before the DNA was precipitated with 0.3 M NaAc, pH
6, and 2.5-vol ethanol. The DNA was resuspended in TE again,
and several more phenol/CHCI, extractions were performed be-
fore the final ethanol precipitation of the DNA.
RNA was prepared from adult female O. volvulus worms using
either the hot phenol (28) or a combination of the guanidinium/
CsCl methods described by Cox (29) and Chirgwin et al. (30),
as described by Taylor et al. (20).
cDNA Synthesis.
￿
TotalRNA of Q volvulus was used to prepare
cDNA by a combination of the methods by Buell et al. (31) and
Wickens et al. (32). The cDNA was methylated, blunt end ligated
to 12-bp EcoRl linkers (Boehringer Mannheim GmbH, Mannheim,
FRG), and digested with EcoRI. The fragments were size frac-
tionated over a Sepharose 4B column (320 x 2 mm), equilibrated
in TE, and 100 mM NaCl.
CloningExperiments, Screening Methods, andDNA Sequencing.
￿
An
expressionlibrary of 0 volvulus was constructed by cloning cDNA
fragments into the unique EcoRI restriction site ofthe expression
vector Xgt11 (33). Phage particles were packaged using commer-
cially prepared extracts by Promega Biotec (Madison, WI). An im-
munochemical screen to identify antigen-expressing bacteriophage
clones was performed as described by Young and Davis (23).
Recombinant clones other than Xgt11 were constructed in the
high expressionvectors pEX34b (24) and pGEXI (25). These vectors
were engineered to express antigens in an inducible fashion with
the RNA polymerase of bacteriophage MS2 and the glutathione-
S-transferase ofSchistosomajaponicum as respective carrier proteins.
Immunological screens ofbacterial colonies that express recom-
binant antigens ofQ volvulus were performed as described by Hall
et al. (34). Fusion proteins, transferred to Nitrocellulose filters, were
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detected using antibody probes and the developing system as de-
scribed for Western blots.
DNA sequences were determined using the M13/dideoxy method
by Sanger et al. (35). Universal M13 and Xgt11 primers were pur-
chased from New England Biolabs (Beverly, MA).
In general, DNA fragments for all subcloning experiments were
isolated from DNA prepared from an original Xgt11 clone and re-
covered from agarose gels using NA-45 cellulose membrane
(Schleicher & Schull, GmbH) (36).
Hybridization Reactions.
￿
DNA/DNA hybridizations were per-
formed under either high stringencyconditions in 50% formamide
at 42°C or atlower stringencyat 38°C using the radiolabeled cDNA
insert fragment as aprobe, prepared by the random primer labeling
technique (37). This probe was used for hybridization (38) of
Southern blots (39) and for bacterial colonies.
Results
Ov39, a cDNA Clone Derived from an Expression Library
of Q volvulus. For the preparation of in vitro translation
products, RNA was extracted from gravid female Q volvulus
worms. The amount of RNA recovered from one female
worm was fV5.9 lcg when prepared by the guanidium/CsCl
method. Slightly less RNA was recovered by the hot phe-
nol/SDS protocol. No major qualitative differences couldbe
detected between the two preparations asjudged by compar-
ison of the SDS-PAGE profiles of mRNAdirected in vitro
translation products (40).
Due to lack of material, and since the amount ofcDNAs
primed on rRNAs by oligo(dT) seems to be negligible (41),
unfractionated RNA rather than poly(A) I RNA was used
to synthesize cDNA for the construction of an expression
library in Xgt11.
An immunological plaque screening of80,000 recombinant
phages was performed usinga pool of human infection sera
preabsorbed against Escherichia coli lysate and 0-galactosidase.
These sera were collected from patients living in an endemic
area ofSierra Leone and present with high microfilaridermia.
Of the clones identified, one designated Ov39 encodes and
stably expresses a 128,000 Mr inducible fusion protein with
galactosidase; the cDNA thus encodes an antigen of
N12,000 M, (Fig. 1, lane 1). The complete sequence of the
cDNA insert consists of 345 by (Fig. 2).
The Kpnl-SStl fragment of AOv39, carrying the lacZ gene
and the cDNA insert, was isolated and subcloned into
M13mp19. The use of a Xgt11-specific primer allowed the
determination of the sequencejunction of the lacZ gene and
the cDNA insert in direction of transcription/translation,
and thus revealed the reading frameofthe cloned DNA. There
is no in-frame stop codon within the cDNA sequence, and
the antigen is expressed with the COOH-terminal 16 amino
acids of the a-galactosidase encoded by the 3' end of the lacZ
gene downstream the EcoRI cloning site. The cDNA insert
encodes 115 amino acids with a calculated molecular mass
of 13,086 daltons. This is in accordance with the relative mo-
lecular mass of the fusion protein established by gel electropho-
resis. The cDNA sequence has stop codons in all three reading
frames when read in inverse orientation, theoretically allowing
the expression of peptides with only 3, 23, or 30 amino acids.Figure 1 .
￿
Expression ofQ volvulus cDNA clone009 as a,6-galactosidase
fusion protein in an E. coli-lysogen . Proteins were electrophoretically sepa-
rated on an 8% acrylamide/SDS gel under reducing conditions, and the
fusion protein was detectedby Western blot, using a pool ofhuman infec-
tion sera . (Lane 1) Induced expression of Xgt11 009 clone, indicated by
arrowhead; (lane 2) control, uninduced lysogen ; (lane 3) induced expres-
sion of Agt1I lysogen as control .
Analysis of the sequence of the cDNA did not reveal a
putative polyadenylation signal nor a poly(A) + tail, and the
3' end does not agree with the sequence of the EcoRI linker
oligo nucleotide that was ligated onto the cDNA . It is as-
sumed that the EcoRI restriction site at the 3' end consti-
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tutes a gene-specific sequence that was not modified by the
methylase reaction of the reverse transcript . Therefore, the
sequence encoding the COON terminus of the antigen as
well as the poly(A) + tail might have been cleaved in the
cloning process.
ThecDNA does not appear to represent the reverse tran-
script of a full-length message, sinceDNA sequence analysis
did not reveal a poly(A) + tail nor a sequence that matches
the consensus sequence for a ribosome binding site (42) . To
identify full-length clones encoding the entire antigen, a
Q volvulus cDNA expression library (no . 37509 ; American
Type Culture Collection, Rockvillc, MD) prepared by Donel-
son et al . (43) in Xgt11 from parasites collected in Central
America (Guatemala) was screened by plaque hybridization
using the cDNA Ov39 insert as a probe. Three clones have
been analyzed that carry an Ov39-like sequence that resides
within a single EcoRI cDNA fragment judged by DNA/
DNA hybridization of Southern blots and that is longer by
59 by as established byDNA sequence analysis . The homol-
ogous cDNA isolates from independent sources are identical
except for one base pair substitution (G - A) in position
176 (Fig. 2), resulting in an arginine residue at position 59
of the antigen in the Sierra Leone isolate in contrast to a gluta-
mine residue in the isolate from Guatemala . All three clones
have an additionalcDNA fragment ofdifferent length at their
5' end . It has not been established whether they are homolo-
gous and derived from the same message, or entirely unrelated.
A search of data bases (EMBL, NBRF, GenBank, PIR,
PIR-NEW, SWISS-Prot, and NEWAT) for nucleotide and
protein sequence homology failed to identify any similarities
with catalogued entries .
Species Specificity ofO09.
￿
The species specificity ofclone
Ov39 was tested by DNA/DNA hybridization ofDNA of
Onchocerca gibsoni, Q gutturosa, Q armillata, Brugia malayi,
B. pahangi, Loa loa, and Acanthocheilonema vitae . Moreover,
it was important to establish whether Ov39 shares any se-
quence homology with human and bovineDNA . Southern
blots of EcoRl-digestedDNA derived from these sources were
hybridized with the cDNA probe ofQ volvulus . The corre-
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Figure 2 .
￿
The nucleotide sequence and predicted amino
acid sequence ofOv39 . The nucleotide residues are num-
bered with respect to the first nucleotide of the cDNA
clone . The single letter amino acid code is used below
each codon and numbered below. The sequence of the
EcoRI linker is indicated in lower case letters . The gene-
specific EcoRl restriction site at the 3' end of the sequence
is underlined.Figure 3 .
￿
Immunoprecipitation of a 22,000M 35S-labeled O volvulus
antigen by rabbit antisera raised against 009 recombinant antigen ex-
pressed in pEX34b and pGEX1 . (Lane 1) Control experiment performed
with serum from rabbit before immunization with fusion protein EX39 ;
(lane 2) immunoprecipitation performed with serum collected from rabbit
immunized with the EX39 fusion protein ; (lane 3) control experiment
performed with serum collected from a rabbit immunized with the carrier
protein expressed by pEX34b; (lane 4) control experiment with rabbit serum
collected before immunization with fusion protein GEX39 ; (lane 5) im-
munoprecipitation of a 22,000M antigen with rabbit anti-GEX39 serum.
The proteins were separated on an 8-20% acrylamide/SDS gel under
reducing conditions .
sponding "gene39" or part of the "gene39" is located on a
2.3-kb EcoRI fragment of genomic DNA ofO volvulus . All
the other Onchocerca species tested have a very closely related
gene that can be localized on a 2.1-, 2.3-, and 1.8-kb EcoRI
fragment ofO gibsoni, O gutturosa, andO armillata, respec-
tively . Homologous gene sequences have been identified on
an 8-kb fragment ofL. loa genomic DNA, and on two frag-
ments of2.3- and 4.2-kb ofR malayi . Less stringent hybrid-
ization conditions reveal only very weak homologies on a
3.7-kb fragment between R pahangi DNA and Ov39, and
entirely failed to identify corresponding sequences in the ge-
nome ofA . vitae, human, andbovine DNA (data not shown) .
Subclones ofOv39.
￿
Clones expressing the gene of Ov39
in bacteria are a ready source to produce large quantities of
recombinant antigen. To obtain fusion proteins with carrier
molecules other than ß-galactosidase, the cDNA fragment
has been subcloned into the high expression vector pGEX1,
in which it is expressed as a 35,000 M r fusion protein
(GEX39) with glutathione-S-transferase of S.japonicum, and
pEX34b, where it is expressed as a fusion protein of 27,000
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Mr (EX39) with a 15,000Mr fragment of the RNA poly-
merase ofphage MS2 . The capacity of human infection sera
to recognize the fusion protein was tested by either ELISA
or Western blot analysis. In the case of theGEX39 antigen,
it was found that background reactivity with the carrier pro-
tein precluded meaningful interpretation of the results (none
of the patients donating sera for these experiments were in-
fected with any species of schistosome) . However, 1 of 16
human infection sera tested in Western blot showed very strong
reactivity against the EX39 recombinant protein (data not
shown) and had no background reactivity against the carrier
peptide of this recombinant protein .
The Native Antigen Ov39.
￿
Rabbit antisera were raised
against both the EX39 and GEX39 fusion protein as well
as against the respective carrier peptides for sera controls . Both
the anti-EX39 and the anti-GEX39 serum recognize the Ov39
antigen of the hybrid molecules and were used in immuno-
precipitation experiments to identify the corresponding na-
tive antigen. An aqueous extract of antigens labeled with
35SLR was reacted with these sera. Both antisera recognize
a water-soluble antigen of 22,000 M r (Fig. 3) .
Immunological Cmssreactivity of009 tvthRPE.
￿
The retinal
pigment epithelium is formed by a cell monolayer, located
immediately under the neurosensory retina . The RPE cells
are attached to the Bruch's membrane, from which they can
be detached and isolated . Components soluble in PBS, 1%
Triton X-100 were analyzed on a Western blot (Fig. 4) . The
extracted components were probed with rabbit hyperimmune
Figure 4.
￿
Identification of a 44,000
M component of RPE, using rabbit
serum raised against the recombinantO
volvulus clone009. Components of the
PBS, 1% Triton X-100-soluble extract
were separated on a 12% acrylamide/SDS
gel under reducing condition, transferred
on nitrocellulose filter, and probed with :
(lane 1) a control serum, collected from
a rabbit before immunization with the
EX39 recombinant antigen; (lane 2) with
test serum collected from the rabbit after
immunization with the EX39 fusion
protein .Figure 5.
￿
Immunoprecipitation ofextracts ofcultured human RPE meta-
bolically labeled with 35S-methionine . (Lane 1) Control, serum of rabbit
before immunization with a total extract of O . volvulus ; (lane 2) serum
ofrabbit immunized against a total extract ofO volvulus; (lane 3) control,
serum ofrabbit immunized with glutathione S-transferase ; (lane 4) con-
trol, serum of rabbit before immunization with the fusion proteinGEX39 ;
(lane 5) rabbit serum raised against the recombinant fusion protein GEX39 .
The proteins were separated on an 8-20% polyacrylamide/SDS gel under
reducing conditions.
serum raised against the EX39 fusion protein (lane 2), and
with the rabbit serum that was taken from the rabbit before
immunization (lane 1) . Neither the sera collected from the
rabbit before immunization with the fusion protein EX39,
nor the serum raised against the carrier protein (RNA poly-
merase of phageMS2) recognized any component of the ex-
tract (data not shown) . However, the anti-EX39 serum reacts
strongly with a 44,000M r molecule of the bovine RPE cell
extract . No reactivity could be seen with components of the
1% Triton X-100-insoluble cytoskeletal fraction (data not
shown) .
Shortage offreshhumanRPE precludes experiments similar
to those described above. To circumvent this problem, human
RPE cells were cultured and metabolically labeled with 'IS-
methionine. Sequential extracts of these cells in PBS, PBS
containing 1% Triton X-100, andSDS were immunoprecip-
itated and subsequently analyzed by SDS-PAGE (Fig. 5) . In
this experiment, a molecule of 44,000 Mr is recognized in
the 1% Triton X-100 fraction by rabbit serum raised against
theGEX39 fusion protein (lane 5) . Again, the control serum
taken from this rabbit before inoculation with GEX39, and
the rabbit serum raised against the carrier protein (glutathione
S-transferase), failed to react with anyRPE component (lanes
4 and 3, respectively) . The anti-GEX39 serum did not react
with components of the PBS nor the SDS extract . In addi-
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tion, a 1% Triton X-100-soluble component ofthe same size
was recognized by a rabbit serum that was raised against a
total extract offemaleQ volvulus worms (lane 2) . Homology
between these two molecules is not proven.
Histological Localization of Target Antigen.
￿
Immunocyto-
chemical studies for the histological localization of the respec-
tive molecule were carried out on cryostat sections ofbovine
retina by the indirect immunofluorescence technique using
the rabbit anti-EX39 serum . Fig. 6A illustrates a light micro-
graph of a section stained with hematoxylin and eosin . The
RPE cell monolayer is indicated by the arrowhead. The choroid
is located below this cell layer and the neuroretina above. Fig.
6, B and C, present immunofluorescence micrographs of
similar sections, where Fig. 6B shows the immunoreactivity
obtained with the serum taken before immunization. Fig .
6 C demonstrates the immunostaining of a section obtained
with the anti-Ov39 recombinant serum . The crossim-
munoreactivity of this serum is clearly directed against the
RPE cell layer. Slight staining can be seen in the neuroretina .
Discussion
Hissette (44), Bryant (45), and Ridely (46), described ocular
fundus changes in onchocerciasis patients that were charac-
terized by atrophy of the pigment epithelium and underlying
choroid . They suggested an association between these lesions
and infection withQ volvulus . Epidemiological and histopatho-
logical evidence supports the causal nature of this association
(47-50) .
Bird et al . (4) have described posterior segment changes
associated with onchocerciasis . Mild or severe pigment epi-
thelial atrophy was present in >50% of individuals studied
with associated choroidal atrophy in more advanced cases .
Although the precise mechanism is unknown, the role of
immune processes in the pathogenesis ofsome of the com-
plications of onchocerciasis has been established (51-53) .
Recently, there has been considerable interest in the role
of antibody responses directed against retinal S antigen and
IRBP, both of which can induce a chorioretinopathy in ex-
perimental animals (54) . It has also been suggested that anti-
bodies with specificity for these proteins may have a role in
the pathogenesis of the chorioretinopathy seen in individ-
uals infected withQ volvulus (55) . A significantly higher level
of S antigen autoantibodies has been found in patients with
posterior pole involvement (11) . However, in other studies,
no correlation between the levels of antibodies against retinal
proteins and the occurrence ofchorioretinitis could be found
(12, 56) .
The formation of anti-S and anti-IRBP antibodies may be
a secondary phenomenon resulting from exposure of antigens
by an underlying disease process. The occurrence of antibodies
against human S antigen and human IRBP may not be
sufficient to cause chorioretinopathy in onchocerciasis. The
observation that experimental autoimmune uveoretinitis can
not be induced by passive transfer of antiretinal antibodies
supports this idea (57, 58) .
Microfilariae occur in the vitreous and choroid, and have
been identified in the retina in vivo (59) and in histological
Crossreactivity of Onchocerca volvulus with Retinal Pigment EpitheliumFigure 6.
￿
(A) Light micrograph of a cryostat section of bovine retina and choroid stained with hematoxylin and eosin. The arrowhead indicates
theRPE . The choroid is below and the neuroretina above. (B) Immunofluorescence micrograph of a similar section probed with serum from a rabbit
before immunization with the recombinant fusion protein EX39 (serum dilution 1:100) . (C) Immunofluorescence micrograph illustrating the staining
obtained using serum collected from the rabbit after immunization with the EX39 fusion protein (serum dilution 1:100) . There is specific staining
of RPE cells (calibration bar = 100 um) .
sections (7) . However, the numbers found in the retina are
apparently lower than found in other regions of the eye. Me-
chanical damage to the retina by microfilariae might there-
fore contribute less to pathology than indirect inflammatory
processes or direct autoantibody reactions based on immuno-
logical crossreactivity of retinal and parasitic molecules . The
idea that autoimmunity may play a role in pathogenesis can
find additional support from the observation that even after
drug treatment, the degenerative ocular processes continue
(60, 61) .
There is no indication that the occurrence of anti-S an-
tigen and anti-IRBP-antibodies in onchocerciasis patients may
be based on crossreactivity with parasitic antigens . However,
the results presented here demonstrate a specific crossreac-
tivity between a component of the RPE and a characterized
recombinant antigen ofO volvulus .
Anti-Ov39 reacts with a 44,000 Mr component of the
RPE, however, this molecule has not been characterized in
detail . IRBP as possible target antigen for the anti-Ov39 can
almost certainly be excluded, since IRBP is a high molecular
weight glycoprotein of 140,000 Mr . S antigen is also
precluded as a target : this antigen has an apparent molecular
weight of 48,000Mr and is localized in the photoreceptor
cells, particularly the outer segment . However, the indirect
immunofluorescence studies performed with the anti-Ov39
serum localized the target antigen in the RPE . No reactivity
could be detected in the photoreceptor outer segments, and
only faint reactivity with the remainder of the neuroretina,
nor was any staining observed on the interphotoreceptor ma-
trix . If the rabbit anti-Ov39 serum contained antibodies with
specificity for S antigen or IR.BP, the expected staining pat-
tern should extend to these retinal layers .
S antigen and IRPB, as well as the components ofthe neural
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retina, are located in a immunologically privileged site pro-
tected by the RPE and endothelial cells of the retinal vascula-
ture . These two cell types form the blood-retinal barrier (62).
Antibodies directed against the recombinant peptide Ov39
crossreact with the retinal pigment epithelium and thus do
not have to cross this barrier. Indeed, they are directed against
a component of the cells that form the blood-retinal barrier.
It was important to establish Ov39 as an authentic para-
site antigen . Results of Southern blot experiments did reveal
similar DNA sequences in other filarial nematodes with
varying degree in human and bovineDNA . This excludes
the possibility that Ov39 might be a human-derived cloning
artefact . The recombinant antigen Ov39 represents -60%
of the total antigen, with the crossreactive determinant . Since
theRNA was extracted from gravid female C1 volvulus worms,
it is to be assumed that the preparation, therefore, contained
RNA from female somatic tissue as well as RNA derived
from embryonic stages and uterine microfilariae . However,
if the anti-Ov39 antibody reactivity should be causative for
any pathological changes in the eye, the source and location
of the parasitic antigen would be irrelevant .
TheOv39 fusion protein is recognized by 1 out of 16human
infection sera so far tested . Whether crossreactivity of this
antigen with the RPE contributes to the pathogenesis ofchori-
oretinitis or choroidal atrophy will have to be established .
Recognition of this antigen byhuman infection seramay corre-
late with chorioretinal changes . In this regard, we have col-
lected, at six monthly intervals over 3 yr, a bank of sera from
"1,200 patient participants in a community-based trial of
ivermectin in Sierra Leone (18) . These sera together with the
purified recombinant will provide the basis for experiments
designed to test this possibility.References
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